<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-H9R14RMM</identifier><date>2017</date><creator>Adeberg, Sebastian</creator><relation>documents/doc/H/URN_NBN_SI_doc-H9R14RMM_001.pdf</relation><relation>documents/doc/H/URN_NBN_SI_doc-H9R14RMM_001.txt</relation><format format_type="issue">4</format><format format_type="volume">51</format><format format_type="type">article</format><format format_type="extent">str. 431-437, V</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">300524288</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-H9R14RMM</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">glioblastom</subject><subject language_type_id="slv">metabolizem</subject><subject language_type_id="slv">metformin</subject><subject language_type_id="slv">obsevanje</subject><subject language_type_id="slv">rak (medicina)</subject><title>Metformin enhanced in vitro radiosensitivity associates with G2/M cell cycle arrest and elevated adenosine-5'-monophosphate-activated protein kinase levels in glioblastoma</title></Record>